Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Successful Innovation in B2B Takes Bringing the Whole Company to the Table

Successful B2B innovation demands cross-functional alignment, a critical factor often overlooked. True innovation requires a disciplined, strategic approach beyond mere brainstorming. Integrating teams across a company can facilitate meaningful and sustainable innovation.

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

By Gerry Mecca · B2b CompaniesEkg GroupGerry MeccaGo-to-market Strategies
Share

Key takeaways

01

Cross-functional alignment is essential for B2B innovation.

02

Discipline and strategy are necessary for true innovation.

03

Integrating company teams leads to sustainable innovation.

In the realm of business, the term 'innovation' is often tossed around like a shiny buzzword, suggesting a world of limitless possibilities and creative experimentation. Especially when tackling innovation in B2B, though, whether in the form of new business models, products, services, or partnerships, true innovation requires far more than mere brainstorming and ideation; it demands a disciplined and strategic approach to transform ideas into tangible, profitable outcomes.

Innovation in B2B takes many forms. In healthcare, digital innovation is creating new competitive edges for medtech and solutions providers as digital payments and AI sweep the industry. Digital transformation is also opening new doors in B2B; companies across industry are seeing value with innovation in B2B that makes embedded analytics a strategic priority and a transformation agent for operations, new services, financial efficacy, and more. Some thought leaders put the emphasis on media strategies being the chief battleground for innovation as B2B works to catch up to B2C and adopt innovative digital marketing strategies.

What really makes for a successful strategy for innovation in B2B, though? Regardless of the market or technology in question, organizational culture that fosters unedited and free-flowing ideas, yet couples this creativity with rigorous mechanisms to ensure these ideas are more than just fleeting thoughts, is the bedrock of any successful mission of innovation in B2B companies. Gerry Mecca, a cutting-edge senior leader in technology and Principal at The EKG Group, shares some of his strategies for making good on promises of innovation, pulling from his 40+ years working in the technology and CPG sectors and consulting businesses on their executive technology strategies.

"I always think of the example of penicillin was invented somewhat accidentally, then innovated once so that it could be taken on to the field in military applications. But the real innovation was when it was made into a pill that people could take. Each of those steps were innovations," Mecca said. "None of those steps would have taken place if somebody didn't sit down and say, here's what we could do or what do you think about this? Get a bunch of smart people together, get them to have a little bit of money to make their innovations become more than just a piece of paper."

Get a bunch of smart people together, get them to have a little bit of money to make their innovations become more than just a piece of paper.
— Gerry Mecca, Principal at The EKG Group

About the author

Gerry Mecca
Gerry MeccaGlobal Chief Information Officer

Cutting-edge Senior Leader whose technology solutions and business acumen have enabled startups as well as established global companies to grow and thrive in highly competitive markets like IngramMicro, Applied Creative Technology, ConocoPhillips, Dr Pepper, Cadbury, Keurig, Datascan, and Tropicana. Works across organizations to develop, communicate and sell an innovative technology vision that drives companies forward.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's expertise into articles, video, and social posts. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

UpDoc has received FDA clearance for its LLM-driven diabetes management app, while Aidoc has been granted breakthrough device status for its AI-drafted radiology reports. This marks a significant milestone as clinical AI applications continue to gain regulatory approval and recognition. The advancements showcase the potential of AI in improving healthcare management and diagnostic processes.

  • 01UpDoc's diabetes management app receives FDA clearance.
  • 02Aidoc achieves breakthrough device status for AI radiology reports.
  • 03Regulatory milestones highlight AI's growing role in healthcare.

Jul 13, 2026

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

The chief data and AI officer at Cedars-Sinai discusses the evolving role of AI in healthcare. While the first wave of AI focused on enhancing productivity, the second wave is expected to transform job roles and the workforce structure. This shift indicates a deeper integration of AI technology in healthcare operations.

  • 01First wave of AI increased productivity in healthcare.
  • 02Second wave aims to restructure job roles.
  • 03AI will deeply integrate into healthcare operations.

Jul 13, 2026

Automation adoption gap widens in US manufacturing as medtech presses ahead

Automation adoption gap widens in US manufacturing as medtech presses ahead

Automation in US manufacturing lags, with 80% of factories lacking automation tools. In contrast, medtech manufacturers are advancing with technologies like micro-molding and ultrasonic welding. This disparity highlights a growing gap in technology adoption across different sectors.

  • 0180% of US factories have no automation.
  • 02Medtech manufacturers are investing in automation technologies.
  • 03There's an increasing divide in technology adoption across industries.

Jul 12, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

About the Expert

Gerry Mecca
Gerry Mecca

Global Chief Information Officer

Cutting-edge Senior Leader whose technology solutions and business acumen have enabled startups as well as established global companies to grow and thrive in highly competitive markets like IngramMicro, Applied Creative Technology, ConocoPhillips, Dr Pepper, Cadbury, Keurig, Datascan, and Tropicana. Works across organizations to develop, communicate and sell an innovative technology vision that drives companies forward.

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512